Chief Technology Officer
Kim Warren has a Ph.D. in Comparative Physiology from Univ. of Maryland and postdoctoral training in Immunology at USUHS, Bethesda MD. Kim is an experienced scientist with entrepreneurial and business management experience, currently consulting in the field of Cell Therapy. She spent the last 10 years at Lonza, developing a services business, including tissue acquisition, process development, bioassays and related services to support GMP manufacturing of cellular therapeutics. Kim also headed R&D at Cambrex, developing cell-based research products. She founded and ran Poietic Technologies, acquired by Cambrex in 1999. She has held research positions in pharma (Otsuka) and biotech (Cetus).